Jane Alder

622 total citations
16 papers, 438 citations indexed

About

Jane Alder is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Jane Alder has authored 16 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Jane Alder's work include RNA Interference and Gene Delivery (3 papers), MicroRNA in disease regulation (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Jane Alder is often cited by papers focused on RNA Interference and Gene Delivery (3 papers), MicroRNA in disease regulation (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Jane Alder collaborates with scholars based in United Kingdom, Spain and Denmark. Jane Alder's co-authors include Lisa Shaw, Rod A. Lea, M G Stone, J. C. Macartney, Clare L. Lawrence, Richard S. Camplejohn, Kamalinder K. Singh, J. Brian Houston, Hayley S. Brown and Andrew Shaw and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and Journal of Medicinal Chemistry.

In The Last Decade

Jane Alder

14 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane Alder United Kingdom	12	252	138	66	66	54	16	438
Michelle Boisdron-Celle France	7	114 0.5×	44 0.3×	33 0.5×	144 2.2×	31 0.6×	9	364
Frank Luh Taiwan	14	388 1.5×	198 1.4×	32 0.5×	147 2.2×	19 0.4×	20	596
Filipa Martins Portugal	8	205 0.8×	135 1.0×	47 0.7×	93 1.4×	23 0.4×	13	378
Hui-Yen Chuang Taiwan	11	246 1.0×	159 1.2×	79 1.2×	124 1.9×	11 0.2×	18	466
Mingzhu Huang China	13	211 0.8×	111 0.8×	24 0.4×	157 2.4×	16 0.3×	36	422
Judong Luo China	11	256 1.0×	82 0.6×	49 0.7×	126 1.9×	11 0.2×	21	450
Mohammed Benkheil Belgium	8	245 1.0×	80 0.6×	26 0.4×	88 1.3×	14 0.3×	8	443
Colin Phipps United States	13	177 0.7×	33 0.2×	56 0.8×	149 2.3×	27 0.5×	19	430
Sven de Mey Belgium	9	213 0.8×	113 0.8×	70 1.1×	148 2.2×	10 0.2×	10	447

Countries citing papers authored by Jane Alder

Since Specialization

Citations

This map shows the geographic impact of Jane Alder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Alder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Alder more than expected).

Fields of papers citing papers by Jane Alder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Alder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Alder. The network helps show where Jane Alder may publish in the future.

Co-authorship network of co-authors of Jane Alder

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Alder. A scholar is included among the top collaborators of Jane Alder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Alder. Jane Alder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Alder, Jane, Erwin Berenschot, Niels R. Tas, et al.. (2025). Structure-Based Discovery Targeting GSK-3α Reveals Potent Nanomolar Selective 4-Phenyl-1H-benzofuro[3,2-b]pyrazolo[4,3-e]pyridine Inhibitor with Promising Glioblastoma and CNS-Active Potential in Cellular Models. Journal of Medicinal Chemistry. 68(8). 8679–8693.

Alder, Jane, et al.. (2023). Overcoming biological barriers BBB/BBTB by designing PUFA functionalised lipid-based nanocarriers for glioblastoma targeted therapy. Biomaterials Advances. 155. 213660–213660. 11 indexed citations

Morais, Camilo L. M., Katherine M. Ashton, Charles H. Davis, et al.. (2022). Raman hyperspectral imaging coupled to three-dimensional discriminant analysis: Classification of meningiomas brain tumour grades. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 273. 121018–121018. 12 indexed citations

Davies, Matthew, Rocío Benítez‐Fernández, Concepción Pérez, et al.. (2021). Structure-Based Design of Potent Selective Nanomolar Type-II Inhibitors of Glycogen Synthase Kinase-3β. Journal of Medicinal Chemistry. 64(3). 1497–1509. 15 indexed citations

Alder, Jane, et al.. (2020). Tailoring functional nanostructured lipid carriers for glioblastoma treatment with enhanced permeability through in-vitro 3D BBB/BBTB models. Materials Science and Engineering C. 121. 111774–111774. 33 indexed citations

Esposito, Carla Lucia, Silvia Nuzzo, Anna Di Rienzo, et al.. (2016). A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells. Journal of Controlled Release. 238. 43–57. 71 indexed citations

Lawrence, Clare L., et al.. (2015). Selective Targeting to Glioma with Nucleic Acid Aptamers. PLoS ONE. 10(8). e0134957–e0134957. 15 indexed citations

Hayes, Josie, Helene Thygesen, Alastair Droop, et al.. (2014). Prediction of clinical outcome in glioblastoma using a biologically relevant nine‐microRNA signature. Molecular Oncology. 9(3). 704–714. 54 indexed citations

Lea, Rod A., et al.. (2014). Circulating MicroRNA Biomarkers for Glioma and Predicting Response to Therapy. Molecular Neurobiology. 50(2). 545–558. 52 indexed citations

10.

Kumar, Sandeep, Lisa Shaw, Clare L. Lawrence, Robert Lea, & Jane Alder. (2014). P50 * DEVELOPING A PHYSIOLOGICALLY RELEVANT BLOOD BRAIN BARRIER MODEL FOR THE STUDY OF DRUG DISPOSITION IN GLIOMA. Neuro-Oncology. 16(suppl 6). vi8–vi8. 5 indexed citations

11.

Ashmore, James, et al.. (2011). Whole Body Oxygen Delivery and Consumption During Cardiopulmonary Bypass Surgery. Advances in experimental medicine and biology. 737. 229–234. 1 indexed citations

12.

Lappin, Graham, Yoko Shishikura, Roeline Jochemsen, et al.. (2011). Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers. European Journal of Pharmaceutical Sciences. 43(3). 141–150. 45 indexed citations

13.

Baxter, M., Cliff Rowe, Jane Alder, et al.. (2010). Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening. Stem Cell Research. 5(1). 4–22. 48 indexed citations

14.

Brown, Hayley S., et al.. (2010). Comparative Use of Isolated Hepatocytes and Hepatic Microsomes for Cytochrome P450 Inhibition Studies: Transporter-Enzyme Interplay. Drug Metabolism and Disposition. 38(12). 2139–2146. 29 indexed citations

15.

Alder, Jane, John A. Pickett, Ian McGovern, et al.. (2003). Changes in Redox Status of Cerebral Cytochrome Oxidase during Periods of Hypoperfusion in Patients Undergoing Cardiopulmonary Bypass. Advances in experimental medicine and biology. 540. 87–92. 1 indexed citations

16.

Macartney, J. C., et al.. (1986). Prognostic importance of DNA flow cytometry in non-Hodgkin's lymphomas.. Journal of Clinical Pathology. 39(5). 542–546. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact